The responding patient had a PD-L1-negative tumor with low tumor mutational burden but high TILs and enriched immune gene expression; further, immunostaining, genomic, and proteomic studies indicated a high degree of tumor immune suppression in the studied population [12]. Here, CD274 is linked to neoplasm.